ES2054932T3 - Preparaciones de liberacion sostenida y proceso de las mismas. - Google Patents

Preparaciones de liberacion sostenida y proceso de las mismas.

Info

Publication number
ES2054932T3
ES2054932T3 ES89111436T ES89111436T ES2054932T3 ES 2054932 T3 ES2054932 T3 ES 2054932T3 ES 89111436 T ES89111436 T ES 89111436T ES 89111436 T ES89111436 T ES 89111436T ES 2054932 T3 ES2054932 T3 ES 2054932T3
Authority
ES
Spain
Prior art keywords
preparations
processes
sustained release
weight
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89111436T
Other languages
English (en)
Inventor
Teruo Sakamoto
Toyohiko Takeda
Yusuke Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2054932T3 publication Critical patent/ES2054932T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PREPACIONES DE LIBERACION PAUSADA CONSISTIENDO ESENCIALMENTE DE UNA PUERTA EN PESO DE UN INGREDIENTE ACTIVO SOLUBLE EN AGUA Y DE 1 A 10 PARTES EN PESO DE 2 O MAS GRASAS, DONDE EL PUNTO DE FUSION ES DIFERENTE UNO DE OTRO, SIENDO CAPACES DE LIBERAR INGREDIENTES ACTIVOS A UN PROPORCION CONSTANTE DURANTE UN LARGO PERIODO DE TIEMPO, Y SIENDO FACIL Y ECONOMICAMENTE FABRICADO.
ES89111436T 1988-07-18 1989-06-23 Preparaciones de liberacion sostenida y proceso de las mismas. Expired - Lifetime ES2054932T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63178757A JP2681373B2 (ja) 1988-07-18 1988-07-18 徐放性製剤の製造法

Publications (1)

Publication Number Publication Date
ES2054932T3 true ES2054932T3 (es) 1994-08-16

Family

ID=16054068

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89111436T Expired - Lifetime ES2054932T3 (es) 1988-07-18 1989-06-23 Preparaciones de liberacion sostenida y proceso de las mismas.

Country Status (6)

Country Link
US (1) US5023089A (es)
EP (1) EP0351580B1 (es)
JP (1) JP2681373B2 (es)
AT (1) ATE89161T1 (es)
DE (1) DE68906477T2 (es)
ES (1) ES2054932T3 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
JPH0624991A (ja) * 1991-06-20 1994-02-01 Tokyo Tanabe Co Ltd ウルソデスオキシコール酸持続性製剤
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5635208A (en) * 1993-07-20 1997-06-03 Mcneil-Ppc, Inc. Granulation process for producing an acetaminophen and diphenhydramine hydrochloride composition and composition produced by same
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5827537A (en) * 1995-05-04 1998-10-27 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
SE9603667D0 (sv) * 1996-10-08 1996-10-08 Astra Ab Pharmaceutical compositions
DE19729487A1 (de) * 1997-07-10 1999-01-14 Dresden Arzneimittel Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE19925710C2 (de) * 1999-06-07 2002-10-10 Byk Gulden Lomberg Chem Fab Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer
CA2376202C (en) * 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel preparation and administration form comprising an acid-labile active compound
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU764453B2 (en) * 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
JP2003530489A (ja) 1999-12-28 2003-10-14 キンバリー クラーク ワールドワイド インコーポレイテッド 放出制御抗菌剤を含むワイプ
US6794318B2 (en) 1999-12-28 2004-09-21 Kimberly-Clark Worldwide, Inc. Use-dependent indicator system for absorbent articles
JP2003527168A (ja) 1999-12-28 2003-09-16 キンバリー クラーク ワールドワイド インコーポレイテッド 硬い表面に用いる放出制御抗菌ワイプ
AU2000273085A1 (en) * 2000-10-02 2002-04-15 Usv Limited Sustained release pharmaceutical compositions containing metformin and method ofits production
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20040146553A1 (en) * 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
CN101534808A (zh) 2005-06-27 2009-09-16 拜维尔实验室国际有限公司 丁氨苯丙酮盐的改良释放配制品
US20080069871A1 (en) * 2006-07-21 2008-03-20 Vaughn Jason M Hydrophobic abuse deterrent delivery system
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
JPS6045846B2 (ja) * 1980-11-14 1985-10-12 理研ビタミン株式会社 Ｌ−アスコルビン酸製剤およびその製造法
JPS5944327A (ja) * 1982-09-06 1984-03-12 Taiyo Kagaku Kk Ｌ−アスコルビン酸およびその塩類の安定化法
US4723930A (en) * 1986-07-16 1988-02-09 Dart Industries Inc. Noah's ark toy
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
EP0335970B1 (en) * 1987-10-05 1992-09-02 Pharmagyn, Inc. Tablet for use in the treatment of progesterone deficiency

Also Published As

Publication number Publication date
ATE89161T1 (de) 1993-05-15
DE68906477T2 (de) 1993-09-09
EP0351580A3 (en) 1990-05-09
EP0351580A2 (en) 1990-01-24
EP0351580B1 (en) 1993-05-12
JPH0232012A (ja) 1990-02-01
JP2681373B2 (ja) 1997-11-26
DE68906477D1 (de) 1993-06-17
US5023089A (en) 1991-06-11

Similar Documents

Publication Publication Date Title
ES2054932T3 (es) Preparaciones de liberacion sostenida y proceso de las mismas.
ES2021049B3 (es) Formulacion de liberacion sostenida y produccion de la misma.
FI901919A0 (fi) Foerbaettrade kompositioner med stoerre vattenloeslighet.
UA26097A1 (uk) Триазиhові похідhі, що мають гербіцидhу активhість, спосіб їх одержаhhя та гербіцидhа композиція hа їх осhові
DE3778244D1 (de) Oestradiol-implantat und verfahren zu seiner herstellung.
DE59208062D1 (de) Pestizidinformulierungen in Form von Mikrokapseln
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
HUT44904A (en) Herbicides comprising 3-phenyl-uracyl derivatives as active ingredient and process for producing the active ingredients and intermediaries thereof
HUT47383A (en) Fungicides and insecticides comprising 2-anilino-pyrimidine derivatives as active ingredient and process for producing the active ingredients
FI914927A0 (fi) Fungicida oxazolidinoner.
DE3888834D1 (de) Herbizides Wirkstoffkonzentrat.
FI885488L (fi) 2,2-difluorisyklopropyylietaanijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö tuholaisten torjunta-aineina
ATE94339T1 (de) Herbizide zusammensetzungen von acylierten 1,3dicarbonyl-herbiziden und antidots dafuer.
DK174931B1 (da) Lægemiddel med langsom frigivelse af den aktive bestanddel
IT7926970A0 (it) Mezzi per l'attivazione e la disattivazione di innesti.
DE3773557D1 (de) Intravaginalartikel und verfahren zu seiner herstellung.
DE69430609D1 (de) Zusammensetzungen von Periproxifen mit verlängerter Freisetzung zur Kontrolle von Parasiten
ATE127683T1 (de) Stabile emulgierte tretinoin-cremeformulierungen.
UA4200A (uk) Спосіб боротьби з небажаною рослинністю
DE68918923D1 (de) Stabile Emulsionsformulierungen von wasserunlöslichen organischen Pestiziden.
DE69002533D1 (de) Indan-1,3-dionderivate und herbizide zusammensetzungen, die diese als aktiven bestandteil enthalten.
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
IT1160892B (it) Derivati dell'urea particolarmente utili come erbicidi e fungicidi e procedimento per la loro preparazione
HUT48096A (en) Insecticides comprising 2-imino-1,3-dithiethane derivatives as active ingredient and process for producing the active ingredients
DE59208063D1 (de) Pestizidformulierungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351580

Country of ref document: ES